Zobrazeno 1 - 10 of 35 pro vyhledávání: '"Diplas, Bh"'
2
Akademický článek
Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.
Autor: Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Sherman EJ; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Wray R; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Boyle JO; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Singh B; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Grkovski M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Paudyal R; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Cunningham L; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Zhang Z; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY., Katabi N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Han J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Imber BS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Pham K; Department of Finance, Memorial Sloan Kettering Cancer Center, New York, NY., Yu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Zakeri K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., McBride SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kang JJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Chen LC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Shah JP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Ganly I; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Cohen MA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Cracchiolo JR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Dunn LA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Michel LS; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Fetten JV; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Kripani A; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Pfister DG; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Ho AL; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Shukla-Dave A; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY., Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Li BT; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Diaz LA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Wong RJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Mar 10; Vol. 42 (8), pp. 940-950. Date of Electronic Publication: 2024 Jan 19.
Zobrazit plný text záznamu
3
Akademický článek
Auto-segmentation of neck nodal metastases using self-distilled masked image transformer on longitudinal MR images.
Autor: Paudyal R; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Jiang J; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Han J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Deasy JO; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Veeraraghavan H; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States., Shukla-Dave A; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.
Publikováno v: BJR artificial intelligence [BJR Artif Intell] 2024 Mar 04; Vol. 1 (1), pp. ubae004. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Zobrazit plný text záznamu
5
Akademický článek
Mining cancer genomes for change-of-metabolic-function mutations.
Autor: Tu KJ; Department of Radiation Oncology, Duke University, Durham, NC, 27710, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 21044, USA.; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, CB2 0RE, UK., Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Regal JA; Department of Radiation Oncology, Duke University, Durham, NC, 27710, USA., Waitkus MS; Department of Neurosurgery, Duke University, Durham, NC, 27710, USA., Pirozzi CJ; Department of Pathology, Duke University, Durham, NC, 27710, USA., Reitman ZJ; Department of Radiation Oncology, Duke University, Durham, NC, 27710, USA. zjr@duke.edu.; Department of Neurosurgery, Duke University, Durham, NC, 27710, USA. zjr@duke.edu.; Department of Pathology, Duke University, Durham, NC, 27710, USA. zjr@duke.edu.
Publikováno v: Communications biology [Commun Biol] 2023 Nov 10; Vol. 6 (1), pp. 1143. Date of Electronic Publication: 2023 Nov 10.
Zobrazit plný text záznamu
6
Akademický článek
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
Autor: Liu H; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Xu C; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Diplas BH; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Brown A; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., Strickland LM; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., Yao H; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Ling J; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., McLendon RE; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Keir ST; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., Ashley DM; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., He Y; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Waitkus MS; The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
Publikováno v: Neuro-oncology [Neuro Oncol] 2023 Sep 05; Vol. 25 (9), pp. 1563-1575.
Zobrazit plný text záznamu
7
Akademický článek
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers.
Autor: Gunn K; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Myllykoski M; Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland; Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland., Cao JZ; Committee on Cancer Biology, Biological Sciences Division, University of Chicago, Chicago, Illinois., Ahmed M; Cancer Signaling and Epigenetics Program, Cancer Epigenetic Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Huang B; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rouaisnel B; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Diplas BH; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Levitt MM; Children's Medical Center Research Institute and Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas., Looper R; Department of Chemistry, University of Utah, Salt Lake City, Utah., Doench JG; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ligon KL; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Pathology, Boston Children's Hospital and Brigham and Women's Hospital, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kornblum HI; Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine at UCLA, Los Angeles, California., McBrayer SK; Children's Medical Center Research Institute and Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas., Yan H; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Duy C; Cancer Signaling and Epigenetics Program, Cancer Epigenetic Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Godley LA; Committee on Cancer Biology, Biological Sciences Division, University of Chicago, Chicago, Illinois.; Section of Hematology/Oncology, Departments of Medicine and Human Genetics, University of Chicago, Chicago, Illinois., Koivunen P; Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland; Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland., Losman JA; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v: Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1478-1497.
Zobrazit plný text záznamu
8
Akademický článek
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers.
Autor: Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Ptashkin R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Chou JF; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Sabwa S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Foote MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rousseau B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Argilés G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., White JR; Resphera Biosciences LLC, Baltimore, Maryland., Stewart CM; Meyer Cancer Center, Weill Cornell Medicine, New York, New York.; New York Genome Center, New York, New York., Bolton K; Department of Medicine, Washington University Medical School, St Louis, Missouri., Chalasani SB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Desai AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Goldberg Z; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Gu P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Li J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Shcherba M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Zervoudakis A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Cercek A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Segal NH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ilson DH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ku GY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Capanu M; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Janjigian YY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Diaz LA Jr; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Maron SB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v: JAMA network open [JAMA Netw Open] 2023 Feb 01; Vol. 6 (2), pp. e2254221. Date of Electronic Publication: 2023 Feb 01.
Zobrazit plný text záznamu
9
Akademický článek
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Autor: Rousseau B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bieche I; Department of Genetics, Institut Curie, Paris, France.; Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France., Pasmant E; Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France.; Fédération de Génétique et Médecine Génomique, Hôpital Cochin, AP-HP Centre-Université de Paris, Paris, France., Hamzaoui N; Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France.; Fédération de Génétique et Médecine Génomique, Hôpital Cochin, AP-HP Centre-Université de Paris, Paris, France., Leulliot N; Cibles Thérapeutiques et Conception de Médicaments, CNRS UMR8015, Université de Paris, UFR de Pharmacie de Paris, Paris, France., Michon L; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France., de Reynies A; Université de Paris, Centre de Recherche des Cordeliers, UMRS1138, AP-HP, SeqOIA-IT, Paris, France., Attignon V; Platform of Cancer Genomics, Centre Léon Bérard, Lyon, France., Foote MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Masliah-Planchon J; Department of Genetics, Institut Curie, Paris, France., Svrcek M; Pathology Department, Saint-Antoine Hospital, Paris, France.; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Cohen R; Sorbonne Université, INSERM, Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France.; Medical Oncology Department, Hôpital Saint-Antoine, Paris, France., Simmet V; Department of Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), Angers, France., Augereau P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), Angers, France., Malka D; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France., Hollebecque A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France., Pouessel D; Department of Medical Oncology, Institut Claudius Regaud/IUCT Oncopole, Toulouse, France., Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud/IUCT Oncopole, Toulouse, France., Guimbaud R; Medical Oncology, CHU de Toulouse, Toulouse, France., Bruyas A; Department of Medical Oncology, Hôpital de la Croix-Rousse, Lyon, France., Guillet M; Department of Gastroenterology and Digestive Oncology, Hôpital de la Croix-Rousse, Lyon, France., Grob JJ; Dermatology and Oncology, Hôpital de la Timone, Marseille, France., Duluc M; Dermatology and Oncology, Hôpital de la Timone, Marseille, France., Cousin S; Oncology, Institut Bergonie, Bordeaux, France., de la Fouchardiere C; Department of medical Oncology, Centre Léon Bérard, Lyon, France., Flechon A; Department of medical Oncology, Centre Léon Bérard, Lyon, France., Rolland F; Department of Medical Oncology, ICO Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain, France., Hiret S; Department of Medical Oncology, ICO Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain, France., Saada-Bouzid E; Medical Oncology, Centre Anticancer Antoine Lacassagne, Nice, France., Bouche O; Gastroenterology and Digestive Oncology, CHU de Reims, Hôpital Robert Debré, Reims, France., Andre T; Medical Oncology Department, Hôpital Saint-Antoine, Paris, France., Pannier D; Oncology, Centre Oscar Lambret, Lille, France., El Hajbi F; Oncology, Centre Oscar Lambret, Lille, France., Oudard S; Oncology, Hôpital Europeen Georges Pompidou, AP-HP, Paris, France., Tournigand C; Oncology, Hôpital Henri Mondor, AP-HP, Creteil, France., Soria JC; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France., Champiat S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France., Gerber DG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Stephens D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Lamendola-Essel MF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Maron SB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Argiles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Krishnan AR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tabone-Eglinger S; Biobank, Centre Léon Bérard, Lyon, France., Ferrari A; Platform of Bioinformatics Gilles Thomas-Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France., Segal NH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Cercek A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Hoog-Labouret N; Research and Innovation, Institut National du Cancer, Boulogne-Billancourt, France., Legrand F; Research and Innovation, Institut National du Cancer, Boulogne-Billancourt, France., Simon C; R&D Department, Unicancer, Paris, France., Lamrani-Ghaouti A; R&D Department, Unicancer, Paris, France., Diaz LA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Saintigny P; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.; Department of medical Oncology, Centre Léon Bérard, Lyon, France., Chevret S; Biostatistics, Hôpital St Louis, Paris, France., Marabelle A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.; U1015 and CIC1428, Institut National de la Santé et de la recherche médicale (INSERM), Villejuif, France.; Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicetre, France.
Publikováno v: Cancer discovery [Cancer Discov] 2022 Jun 02; Vol. 12 (6), pp. 1435-1448.
Zobrazit plný text záznamu
10
Akademický článek
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease.
Autor: Diplas BH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Shahrokni A; Department of Medicine, Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY., Warner A; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Iyengar P; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX., Yang JT; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Gomez DR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Palma DA; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: tsaic@mskcc.org.
Publikováno v: Seminars in radiation oncology [Semin Radiat Oncol] 2022 Apr; Vol. 32 (2), pp. 135-141.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje